Dr. Kathrine Jebian Whitehead, MD

Dr. Whitehead practices at SSM Health St. Mary's Hospital - Centralia in Centralia, Illinois, part of SSM Health Care.

Dr. Whitehead's NPI, 1437194404, was assigned on June 16, 2006. Dr. Whitehead holds Georgia license 55353.

Dr. Whitehead's primary practice is SSM Health St. Mary's Hospital - Centralia, at 400 North Pleasant Avenue, Centralia, IL 62801 in Marion County. The practice phone is (618) 436-8000.

Dr. Whitehead's primary practice is SSM Health St. Mary's Hospital - Centralia in Centralia, Illinois, part of SSM Health Care. Dr. Whitehead is also affiliated with Salem Township Hospital. The medical group on file is Midwest Emergency Department Services (MEDS). Dmand AI also links Dr. Whitehead to 3 more group practices and clinics, 3 medical groups and 1 breast imaging center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Whitehead practices, 6 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Whitehead's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Whitehead is licensed in Georgia.

CMS data shows 416 Medicare services from Dr. Whitehead across 3 procedure codes in 2024, for 368 Medicare patients. Medicare paid $52,022 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 368 Medicare patients who saw Dr. Whitehead in 2024. The largest group is 65 to 74, with 116 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 57% are also on Medicaid. Their average risk score is 2.34, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Whitehead's median patient age at 65, with 56% women.

In 2024, Dr. Whitehead wrote 259 Medicare Part D claims for 132 patients. 97% of them were for generic drugs. CMS names the drug for 156 of them, across 8 drugs with 11 or more claims each, at $983 in total drug cost. In 2023, CMS named 137 claims across 7 drugs.